Show simple item record

Differential expression of an α-galactosyl-containing trisaccharide on high- and low-malignant murine sarcoma cells: Identification and regulation

dc.contributor.authorVarani, Jamesen_US
dc.contributor.authorPetryniak, Jerzyen_US
dc.contributor.authorTakagaki, Masaruen_US
dc.contributor.authorDame, Michael K.en_US
dc.contributor.authorPetryniak, Bronislawaen_US
dc.contributor.authorGoldstein, Irwin J.en_US
dc.date.accessioned2006-09-08T20:29:48Z
dc.date.available2006-09-08T20:29:48Z
dc.date.issued2002-01en_US
dc.identifier.citationVarani, James; Petryniak, Jerzy; Takagaki, Masaru; Dame, Michael K.; Petryniak, Bronislawa; Goldstein, Irwin J.; (2002). "Differential expression of an α-galactosyl-containing trisaccharide on high- and low-malignant murine sarcoma cells: Identification and regulation." Clinical & Experimental Metastasis 19(1): 1-8. <http://hdl.handle.net/2027.42/42582>en_US
dc.identifier.issn0262-0898en_US
dc.identifier.issn1573-7276en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/42582
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11918078&dopt=citationen_US
dc.description.abstractPast studies have shown that carbohydrate residues reactive with the Griffonia simplicifolia isolectin B 4 (GS I-B4) are present on the surface of highly-malignant murine sarcoma cells but are lacking or expressed in much lower amounts on the surface of low-malignant cells isolated from the same parent tumors (Am J Pathol 111: 27; J Nat Cancer Inst 71: 1281). In the present study it is shown that an antibody which recognizes the trisaccharide Galα1-3Galβ1-4GlcNAc- is reactive with the highly-malignant cells but is non-reactive with the low-malignant cells. Further studies show that the high-malignant cells not only bind GS I-B 4 but also bind Evonymus europaea lectin (which like GS I-B 4 recognizes terminal galactose in α1-3 linkage) and Erythina crystagalli lectin (which recognizes sub-terminal galactose in the β1-4 linkage – e.g., Galβ1-4GlcNAc). In contrast, the low malignant cells bind Erythina crystagalli lectin as efficiently as the high malignant cells but do not bind (or bind much smaller amounts of) either GS I-B 4 or Evonymus europaea lectin. The present studies also show that there is no significant difference between high- and low-malignant cells in expression of α-galactosidase activity. In contrast, the high-malignant cells express high levels of α-galactosyl transferase activity while this enzyme is virtually undetectable in low-malignant cells. Taken together, these studies indicate that differential expression of a single monosaccharide residue distinguishes high- and low-malignant murine sarcoma cells. These studies also identify a mechanism to account for surface carbohydrate differences between the high- and low-malignant cells.en_US
dc.format.extent458117 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springer Science+Business Mediaen_US
dc.subject.otherLectinsen_US
dc.subject.otherMetastasisen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherCancer Researchen_US
dc.subject.otherOncologyen_US
dc.subject.otherHematologyen_US
dc.subject.otherSurgical Oncologyen_US
dc.subject.otherα-Galactosylen_US
dc.subject.otherCarbohydratesen_US
dc.subject.otherGlycosidaseen_US
dc.subject.otherGlycosyl Transferaseen_US
dc.titleDifferential expression of an α-galactosyl-containing trisaccharide on high- and low-malignant murine sarcoma cells: Identification and regulationen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Pathology and Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartments of Pathology and Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartments of Pathology and Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartments of Pathology and Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartments of Pathology and Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartments of Pathology and Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid11918078en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/42582/1/10585_2004_Article_380463.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1013865411941en_US
dc.identifier.sourceClinical & Experimental Metastasisen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.